Fallopian Tube Neoplasms: all 734 studies
Page 6 of 8. Open to participants first (128), then studies with results posted, then the rest; newest registration first within each.
- Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or RecurrentWithdrawnNCT02470559Phase 1
- Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer PatientsCompletedNCT02470299Not applicable
- Autologous OC-L Vaccine and Ovarian CancerTerminatedNCT02452775Phase 1
- Guided Imagery in the Perioperative Period in Gynecologic Oncology PatientsCompletedNCT02444195Not applicable
- p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal CancerStatus unknownNCT02435186Phase 2
- Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of MalignanciesStatus unknownNCT02433626Phase 1
- Clinical Trial of Intraperitoneal Hyperthermic ChemotherapyStatus unknownNCT02349958Phase 2
- A Trial of Vigil for Participants With Ovarian CancerActive, not recruitingNCT02346747Phase 2
- Detection of Chlamydia DNA by Polymerase Chain Reaction in Primary Tubal and Ovarian Cancers Tissues : a Pilot StudyCompletedNCT02343510
- Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal CarcinomaStatus unknownNCT02328716Phase 3
- Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in RemissionCompletedNCT02324439Phase 1
- Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02316834Early Phase 1
- p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial CancerCompletedNCT02275039Phase 1
- Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid TumorsCompletedNCT02262455Phase 1
- mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and OvarianActive, not recruitingNCT02208375Phase 1
- Neoadjuvant Chemotherapy in Epithelial Ovarian CancerStatus unknownNCT02125513Phase 2
- HOT: HIPEC in Ovarian Cancer as Initial TreatmentActive, not recruitingNCT02124421Phase 2
- OVArian Cancer Non-Interventional Study - OVATARCompletedNCT02122588
- Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube CancerCompletedNCT02121990Phase 1
- Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerCompletedNCT02111941Early Phase 1
- Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerWithdrawnNCT02050009Phase 1
- Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02046421Phase 1
- Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02042430Early Phase 1
- Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in RemissionWithdrawnNCT01982487Phase 1/2
- Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal CancerActive, not recruitingNCT01970722Phase 1
- Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian CancerCompletedNCT01940172Phase 1
- An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal CancerCompletedNCT01932125Phase 4
- Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive PatientsCompletedNCT01905163Phase 2
- PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian CancerCompletedNCT01899599Phase 2
- "Re-Stimulated" TILs And IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal CancerActive, not recruitingNCT01883297Phase 1
- Validation of a Nutrition Screening ToolCompletedNCT01851928
- 18F-CP18 Imaging Studies for Cancer Treatment With BirinapantWithdrawnNCT01766622Phase 2
- Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast CancerCompletedNCT01764802Phase 2
- Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerCompletedNCT01764789Not applicable
- Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube CancerCompletedNCT01749397Phase 1
- Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01747798Early Phase 1
- Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line TherapyCompletedNCT01709487Phase 1/2
- Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal CancerCompletedNCT01673217Phase 1
- Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal CancerCompletedNCT01670799Early Phase 1
- First-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian CancerCompletedNCT01669226Phase 2
- Olaparib for Patients With Recurrent BRCA Deficient Ovarian CancerWithdrawnNCT01661868Phase 2
- Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological CancerCompletedNCT01652794Phase 1
- CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal CancerCompletedNCT01652079Phase 2
- A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal CancerCompletedNCT01649336Phase 1
- Interactive Educational Website for Women With Ovarian Cancer & CaregiversCompletedNCT01626014Early Phase 1
- Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian CancerCompletedNCT01610869Phase 2
- Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01606241Phase 1
- Structural and Functional Imaging and Cognitive Functions in Ovarian CancerCompletedNCT01591772
- A Survivorship Care Plan for Gynaecological Cancer PatientsCompletedNCT01582906
- A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal CancerStatus unknownNCT01570582Phase 2
- The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian CancerCompletedNCT01556841Phase 2
- Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerCompletedNCT01536054Phase 1
- Intraperitoneal Therapy For Ovarian Cancer With Carboplatin TrialCompletedNCT01506856Phase 2/3
- Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01504126Early Phase 1
- TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian CancerTerminatedNCT01493505Phase 3
- Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing ChemotherapyWithdrawnNCT01492920Phase 3
- A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid TumorsCompletedNCT01478685Phase 1
- Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian CancerCompletedNCT01471483
- Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian CancerCompletedNCT01462890Phase 3
- Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT01459380Phase 1
- Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian CancerCompletedNCT01442051Not applicable
- Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal CancerCompletedNCT01416038Phase 1
- Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal CancerCompletedNCT01402271Phase 1/2
- Search for Predictors of Therapeutic Response in Ovarian CarcinomaCompletedNCT01391351Not applicable
- Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal CancerStatus unknownNCT01372787
- Pelvic Floor Disorders in Survivors of Gynecologic MalignanciesCompletedNCT01370122
- Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube CancerStatus unknownNCT01366183
- Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian CancerTerminatedNCT01312376Phase 1
- Therapeutic Targeting of Stress Factors in Ovarian Cancer PatientsCompletedNCT01308944Phase 1
- A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic CancerCompletedNCT01281514Phase 1
- AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)TerminatedNCT01281254Phase 3
- Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian CancerTerminatedNCT01279291Phase 1
- Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CTActive, not recruitingNCT01276574
- Endoxifen in Adults With Hormone Receptor Positive Solid TumorsCompletedNCT01273168Phase 1
- Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally InvasiveCompletedNCT01262040Not applicable
- Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian CancerCompletedNCT01253681Phase 1
- Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s CancersCompletedNCT01237067Phase 1
- A Prospective Trial of COXEN Chemotherapy PredictionWithdrawnNCT01228942Not applicable
- Study of Intraperitoneal Carboplatin with IV Paclitaxel and Bevacizumab in Untreated Ovarian CancerCompletedNCT01220154Phase 1
- Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological CancerCompletedNCT01216813
- TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube CancerCompletedNCT01204749Phase 3
- Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian CancerCompletedNCT01196559Phase 2
- Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal CancerCompletedNCT01170299Not applicable
- Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian CancerCompletedNCT01166737Not applicable
- Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube CancerWithdrawnNCT01131039Phase 2
- Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerStatus unknownNCT01100372Phase 2
- Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid TumorTerminatedNCT01096381
- Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel ObstructionTerminatedNCT01083537Phase 1/2
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving ChemotherapyCompletedNCT01080521
- Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT01074411Phase 1
- Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182Status unknownNCT01074398
- AZD2171 and Temsirolimus in Patients With Advanced Gynecological MalignanciesCompletedNCT01065662Phase 1
- Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer CasesCompletedNCT01048814
- Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00989651Phase 1
- Study of Paclitaxel in Patients With Ovarian CancerCompletedNCT00989131Phase 3
- Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)CompletedNCT00959582Phase 1
- Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological CancerStatus unknownNCT00905658Phase 2
- YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving ChemotherapyTerminatedNCT00899093
- Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT00897442
- Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerStatus unknownNCT00897039